MASSDEVICE ON CALL — Renal denervation has been among the hottest new areas for medical device research & development, but the time and money put in has yet to pay off in a big way, according to medtech analyst Joseph Gregory.
Renal denervation hogged headlines and spotlights at conferences around the world last year, but the message in 2013 is a much more sober one: the technology hasn’t taken off as quickly as the industry might have hoped.